Moneycontrol PRO
HomeNewsIndiaCoronavirus outbreak | Govt panel lists essential medicines that may run out of stock: Report

Coronavirus outbreak | Govt panel lists essential medicines that may run out of stock: Report

Around 32 drugs were categorised as critical and essential, 15 as non-critical and essential and seven drugs as essential

March 03, 2020 / 09:40 IST

India may run out of supplies of some essential medicines as the coronavirus outbreak has interrupted import of key raw materials from China, The Economic Times reported.

The drugs that may run out of supply include crucial antibiotics such as amoxicillin, moxifloxacin, doxycycline and tuberculosis (TB) drug rifampicin, the report said.

The publication said it viewed a report submitted by a high-level government committee to the Department of Pharmaceuticals (DoP) last week. Of the 54 drugs reviewed by the panel, 34 do not have an alternative, the report stated.

Moneycontrol could not independently verify the report.

Around 32 drugs were categorised as critical and essential, 15 as non-critical and essential and seven drugs as essential, the report stated.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Active pharmaceutical ingredients (APIs) such as potassium clavulanate, ceftriaxone sodium sterile, piperacillin tazobactum, meropenam, vancomycin, gentamycin and ciprofloxacin have no alternatives and are used in the manufacture of critical and essential drugs, it said.

The panel had asked Indian Council of Medical Research (ICMR) to review the medicines, the report added.

Of the medicines reviewed by ICMR, 38 are part of the National List of Essential medicines (NLEM) and Schedule 1 of the Drug Price Control Order, it said.

It is mandatory for drugs listed under the NLEM to be available in adequate supply. Such medicines should also be sold at prices set by the National Pharmaceutical Pricing Authority (NPPA).

After new cases of coronavirus were reported in India on March 2, the government scheduled a number of meetings on March 3, sources told the paper.

Globally, over 3,000 people have died from the new coronavirus, or COVID-19. In India, six confirmed cases of coronavirus have been reported so far.

Moneycontrol News
first published: Mar 3, 2020 09:40 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347